As of 2026-03-16, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (99.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.58 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -1143.2%.
The range of the Relative Valuation is (97.73) - (99.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 24.8x | 23.6x |
| Forward P/E multiples | 19.9x - 22.4x | 21.6x |
| Fair Price | (97.73) - (99.23) | (99.94) |
| Upside | -1120.2% - -1135.9% | -1143.2% |
| Date | P/E |
| 2026-03-13 | -1.77 |
| 2026-03-12 | -1.78 |
| 2026-03-11 | -1.88 |
| 2026-03-10 | -1.84 |
| 2026-03-09 | -1.83 |
| 2026-03-06 | -1.78 |
| 2026-03-05 | -1.85 |
| 2026-03-04 | -1.90 |
| 2026-03-03 | -1.92 |
| 2026-03-02 | -2.12 |
| 2026-02-27 | -2.07 |
| 2026-02-26 | -2.00 |
| 2026-02-25 | -2.07 |
| 2026-02-24 | -2.13 |
| 2026-02-23 | -2.08 |
| 2026-02-20 | -2.02 |
| 2026-02-19 | -2.04 |
| 2026-02-18 | -2.07 |
| 2026-02-17 | -2.06 |
| 2026-02-13 | -2.04 |
| 2026-02-12 | -2.06 |
| 2026-02-11 | -2.11 |
| 2026-02-10 | -2.19 |
| 2026-02-09 | -2.29 |
| 2026-02-06 | -2.08 |
| 2026-02-05 | -1.93 |
| 2026-02-04 | -1.97 |
| 2026-02-03 | -2.04 |
| 2026-02-02 | -2.11 |
| 2026-01-30 | -2.12 |
| 2026-01-29 | -2.17 |
| 2026-01-28 | -2.19 |
| 2026-01-27 | -2.27 |
| 2026-01-26 | -2.29 |
| 2026-01-23 | -2.43 |
| 2026-01-22 | -2.47 |
| 2026-01-21 | -2.31 |
| 2026-01-20 | -2.28 |
| 2026-01-16 | -2.36 |
| 2026-01-15 | -2.14 |
| 2026-01-14 | -2.10 |
| 2026-01-13 | -1.97 |
| 2026-01-12 | -2.13 |
| 2026-01-09 | -1.99 |
| 2026-01-08 | -2.04 |
| 2026-01-07 | -2.11 |
| 2026-01-06 | -1.73 |
| 2026-01-05 | -1.78 |
| 2026-01-02 | -1.95 |
| 2025-12-31 | -2.03 |